NANJING VAZYME BIOTECH CO.,LTD

Highlights Nanjing Vazyme Biotech Co.,Ltd

Equities

688105

CNE100004ZK3

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
22.95 ^CNY	-0.22%		-5.01%	-28.33%

26/04	Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/04	Nanjing Vazyme Biotech Unit Gets Nod to Register Six Medical Devices; Shares Slump 14%	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	27/04	CI
Nanjing Vazyme Biotech Unit Gets Nod to Register Six Medical Devices; Shares Slump 14%	15/04	MT
China stocks rise after new guidelines; HK shares drop	15/04	RE
Nanjing Vazyme Biotech Swings to Loss in 2023	29/02	MT
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 160 million worth of its shares.	06/02	CI
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	05/02	CI
Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.	24/11	CI
Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback announced on August 22, 2023, has closed with 618,077 shares, representing 0.15% for CNY 20.01 million.	24/11	CI
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Nanjing Vazyme Biotech Plans Up to 30 Million Yuan Share Buyback	22/23/22	MT
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	22/23/22	CI
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	21/23/21	CI
Vazyme Biotech Registers New Pneumonia Pathogen Detection Kit	23/23/23	MT
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Nanjing Vazyme Biotech Unit Gets Registration Certificate for Pneumonia-Detecting Kit	19/23/19	MT
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer